IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in IDEAYA Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- +16 vs. Q2 2022
- Shares held
- 44.7M
- +9.28M (+26.2%) vs. Q2 2022
- Total value
- $667.1M
- +$178.2M (+36.4%) vs. Q2 2022
- New holders
- 28
- 47 more added
- Sold out
- 12
- 22 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,743,628 | $26.0M | 0.52% | +1,743,628 | New |
| Adage Capital Partners GP, L.L.C. | 1,850,094 | $27.6M | 0.07% | +1,745,693+1,672.1% | Added |
| Price T Rowe Associates Inc | 1,858,877 | $27.7M | 0.00% | −27,375−1.5% | Reduced |
| State Street Corp | 1,900,381 | $28.4M | 0.00% | +418,227+28.2% | Added |
| Vanguard Group Inc | 1,924,600 | $28.7M | 0.00% | +171,759+9.8% | Added |
| Boxer Capital, LLC | 2,202,812 | $32.9M | 1.85% | 00.0% | Unchanged |
| Canaan Partners X LLC | 2,660,713 | $39.7M | 62.26% | 00.0% | Unchanged |
| BlackRock Inc. | 2,675,556 | $39.9M | 0.00% | +53,268+2.0% | Added |
| Federated Hermes, Inc. | 2,862,091 | $42.7M | 0.13% | +700,000+32.4% | Added |
| BVF Inc | 3,294,859 | $49.2M | 2.03% | +500,000+17.9% | Added |
| Avidity Partners Management LP | 3,715,400 | $55.4M | 1.21% | +742,453+25.0% | Added |
| Logos Global Management LP | 4,135,000 | $61.7M | 7.61% | +385,000+10.3% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,509,000−100.0% | Sold out |
| Alphabet Inc. | 0 | $0 | 0.00% | −753,187−100.0% | Sold out |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −173,500−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −130,380−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −99,982−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −24,372−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −23,083−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −15,896−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,099−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −12,027−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −738−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −186−100.0% | Sold out |